Search the Newsreel

Alpha Cognition Inc. (ACOG) Reports Q2 Loss, Tops Revenue Estimates

Alpha Cognition Inc. Q2 2026: Revenue $6.09M, EPS $(0.40) — 10-Q Summary

Alpha Cognition Inc. (ACOG) reported its Q2 2026 results, showing revenues of $6.09 million, a significant increase year-over-year due to product sales from the newly launched ZUNVEYL. Despite higher product sales, the company posted a net loss of $8.79 million, although this was an …

Pretax income of Paysign, Inc. – DUS:2ZE

This page displays financial information for Paysign, Inc. (DUS:2ZE) on the Dusseldorf Stock Exchange, specifically focusing on its pretax income. The article provides a high-level overview of the company's financials without specific figures. It also lists various features and services offered by TradingView.

VeriSign CEO D. James Bidzos Executes Sale of 3,300 Shares Under Rule 10b5-1 Plan

VeriSign Inc.'s Executive Chairman, President, and CEO, D. James Bidzos, sold 3,300 shares of the company's common stock on August 11, 2026. These transactions were executed under a Rule 10b5-1 trading plan at weighted average prices ranging from $287.799 to $294.4706 per share. Following …

MGNI Stock Eyes Fourth Week Of Gains: Why This Analyst Thinks Magnite Still Has 26% Upside?

Docusign to Announce Second Quarter Fiscal 2027 Financial Results on September 3, 2026

Docusign (Nasdaq: DOCU) announced it will release its second quarter fiscal 2027 financial results after the U.S. markets close on Thursday, September 3, 2026. The company will host a conference call and live webcast on the same day at 5:00 p.m. Eastern Time to …

Co-Diagnostics (CODX) posts Q2 loss and flags going concern, raises new equity

Co-Diagnostics (CODX) reported significant losses and minimal revenue for Q2 2026, leading management to flag substantial doubt about its ability to continue as a going concern without additional capital. The company posted a net loss of $6.3 million for the quarter and $15.4 million …

Co-Diagnostics (CODX) Stock Falls on Q2 2026 Earnings

CODX Stock Explodes Over 630% In Six Sessions – Retail Traders Bet The Rally Isn’t Over Yet

Co-Diagnostics (CODX) shares surged by nearly 80% on Tuesday, extending a six-session rally that has seen the stock climb over 630%. This surge is attributed to the company's expanded efforts to develop a PCR test for the Bundibugyo strain of the Ebola virus, amidst …

Why (VRSN) Price Action Is Critical for Tactical Trading

This article analyzes Verisign Inc. (NASDAQ: VRSN) stock, highlighting conflicting sentiment across different time horizons and a mid-channel oscillation pattern. It presents an exceptional 33.9:1 risk-reward short setup and outlines three AI-generated trading strategies: Position Trading, Momentum Breakout, and Risk Hedging, along with multi-timeframe …

Alpha Cognition reports Q2 revenue growth, narrows loss By Investing.com

ALPHA COGNITION ($ACOG) Releases Q2 2026 Earnings, Stock Rises

ALPHA COGNITION ($ACOG) announced its Q2 2026 earnings, reporting -$0.40 per share, which met analyst estimates, and revenue of $6,090,000, exceeding expectations. Following the announcement, the stock price rose by 8.7%. The article also details recent insider trading activity, with significant purchases, and outlines …

Verisign (VRSN) CEO D. James Bidzos sells 3,300 shares in planned trades

Verisign's CEO, D. James Bidzos, sold 3,300 shares of the company's common stock on August 11, 2026, through six open-market transactions. These sales were executed under a Rule 10b5-1 trading plan, with weighted-average prices ranging from $287.46 to $294.80 per share. After these transactions, …

Docusign Schedules Sept. 3 Webcast on Results and Outlook

Co-Diagnostics Reports Second Quarter 2026 Financial Results

Co-Diagnostics, Inc. announced its financial results for the second quarter ended June 30, 2026, reporting revenue of $0.17 million and a net loss of $6.3 million. The company highlighted significant operational progress, including advancing manufacturing in Saudi Arabia, expanding commercial outreach in Europe and …

Cigna Group declares Q3 2026 distribution of R$ 0.22 per unit, payable Sept. 29

The Cigna Group has announced a Q3 2026 cash distribution of R$ 0.22 per unit (ISIN BRC1ICBDR000). Shares will trade with entitlement through September 3, 2026, with the payment scheduled for September 29, 2026. This news brief was generated by Public Technologies using AI …

Align Climbs to No. 1,572 on the 2026 Inc. 5000

Align, a global provider of technology infrastructure solutions and Managed IT Services, has been named to the 2026 Inc. 5000 list for the third consecutive year, ranking at No. 1,572. This marks a significant advancement from its previous rankings, driven by increased demand for …

AGNC Investment Corp. (AGNC) Latest Stock News & Headlines

BNP Paribas Initiates Ermenegildo Zegna NV(ZGN.US) With Sell Rating, Announces Target Price $12.2

BNP Paribas has initiated coverage on Ermenegildo Zegna NV (ZGN.US) with a "Sell" rating. The firm has set a target price of $12.2 for the luxury fashion company's stock.

Magnum Ice Cream (NYSE:MICC) Sets New 12-Month High - Here's What Happened

Coreweave Rallies on Upbeat Q2 Results. How to Trade CRWV Stock Here.

AI infrastructure companies have been having a ball this week. It started with a bang after bellwether Nvidia (NVDA) essentially turned its GPUs into an asset class with a $500 billion war chest and some of the leading asset managers of the world, including …

KRSNAA: Revenue and profit rose, dividend declared, and warrants issued to promoters amid tax appeals

Invesco Ltd. (ALHC) reports beneficial ownership of 10.4M Alignment Healthcare shares

Invesco Ltd. has reported beneficial ownership of 10,365,640 shares of Alignment Healthcare Inc. common stock, representing 5.0% of the outstanding class. The shares are held by clients of Invesco's advisory entities, with Invesco retaining sole voting power over 9,985,762 shares and sole dispositive power …

Align Technology Inc. stock underperforms Thursday when compared to competitors despite daily gains

Align Technology Inc. (ALGN) stock increased by 1.26% on Thursday, closing at $176.20. Despite this daily gain, the stock underperformed compared to the broader market, as the S&P 500 rose 0.65% and the Dow Jones Industrial Average increased by 0.13%. This marks the second …

VeriSign Inc. stock outperforms competitors on strong trading day

VeriSign Inc. (VRSN) saw its stock rally by 1.49% to $287.15, outperforming the broader market which also experienced a favorable trading day. This rise ended a three-day losing streak for the company. The S&P 500 Index rose by 0.65% and the Dow Jones Industrial …

EKF Diagnostics Cancels 40,000 Shares in Targeted Buyback

Agnico-Eagle Mines Ltd. stock falls Thursday, underperforms market

Agnico-Eagle Mines Ltd. (AEM) shares dropped 2.44% on Thursday, closing at C$251.52. This performance underperformed the broader Canadian market, with the S&P/TSX Composite Index rising 0.26%. The stock is also 27.9% below its 52-week high of C$348.94 achieved on March 2nd.

Magnera Corp trades at a discount with strong earnings growth and deleveraging post-merger in nonwoven industry.

Magnera Corporation (MAGN), formed from the merger of Glatfelter and Berry's HHNF businesses, is successfully integrating operations, growing earnings, and reducing debt in the nonwoven industry. The company is currently undervalued, trading at 5.5x FY26E EBITDA compared to peers at 9x, with a free …

Needham reiterates Buy on Lucid Diagnostics stock, $3 target

Needham has reiterated a Buy rating and a $3.00 price target for Lucid Diagnostics Inc (NASDAQ:LUCD), citing potential upside from its current stock price of $0.97. The firm anticipates increased revenue growth as the company gains coverage for its EsoGuard test, especially with a …

BLBD vs. FSS: Which Stock Is the Better Value Option?

Investors looking for stocks in the Automotive - Domestic sector might want to consider either Blue Bird (BLBD) or Federal Signal (FSS). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out. …

VeriSign CEO James Bidzos Sells 3,300 Shares for $979,000

VeriSign CEO James Bidzos sold 3,300 shares of the company's common stock for $979,000, as reported in an SEC Form 4 filing. This sale represents a minor adjustment to his holdings, impacting 0.8% of his direct shares, but occurred during a period of strong …

Alpha Cognition (ACOG) doubles H1 2026 revenue as cash burn accelerates

Alpha Cognition Inc. (ACOG) reported significant revenue growth in Q2 2026 and H1 2026, driven by strong sales of its Alzheimer's drug ZUNVEYL, with Q2 revenue up 283% year-over-year and H1 revenue up 110%. Despite this, the company remains unprofitable with a net loss …

Magnera (MAGN) Q3 2026 Earnings Call Transcript

Magnera (MAGN) reported a strong Q3 2026, with net sales increasing by 2% to $857 million and adjusted EBITDA up 9% to $99 million, driven by merger synergies and Project CORE initiatives. The company reaffirmed its full-year free cash flow guidance of $90 million …

How Strong Q2 Results, Higher 2026 Sales Outlook, And Buybacks At Federal Signal (FSS) Have Changed Its Investment Story

Federal Signal (FSS) reported strong Q2 2026 results with increased sales and net income, slightly raising its full-year 2026 net sales outlook. The company also completed a share buyback program and highlighted an active acquisition pipeline, aiming to expand its product portfolio and earnings …

Securities Fraud Investigation Into Alignment Healthcare, Inc. (NASDAQ: ALHC) Following Whistleblower Lawsuit Of Financial Manipulation Continues

Glancy Prongay Wolke & Rotter LLP is continuing its investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) following allegations of federal securities law violations. This comes after a whistleblower lawsuit filed by a former executive claimed the company manipulated its finances by misclassifying operating expenses …

Magnolia Beats Q2 Earnings on Higher Volumes and Price Realization

Magnolia Oil & Gas Corporation MGY reported a second-quarter 2026 net profit of 99 cents per share, which beat the Zacks Consensus Estimate of 90 cents. The bottom line more than doubled from the year-ago quarter's 43 cents. This outperformance can be attributed to …